- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiac arrhythmia considerations of hormone cancer therapies
Authors
Keywords
-
Journal
CARDIOVASCULAR RESEARCH
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-01-25
DOI
10.1093/cvr/cvz020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Are all gonadotrophin-releasing hormone agonists equivalent for the treatment of prostate cancer? A systematic review
- (2018) Eva M. Bolton et al. BJU INTERNATIONAL
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- (2018) Joe-Elie Salem et al. CIRCULATION
- Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects
- (2018) M. Pistelli et al. Current Oncology
- Hormone receptor–positive, HER2-negative metastatic breast cancer: redrawing the lines
- (2018) A. Matutino et al. Current Oncology
- Discovery of LSZ102, a Potent, Orally Bioavailable Selective Estrogen Receptor Degrader (SERD) for the Treatment of Estrogen Receptor Positive Breast Cancer
- (2018) George S. Tria et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of theα-Subunit of Phosphoinositide 3-Kinase in Heart Increases Late Sodium Current and Is Arrhythmogenic
- (2018) Tao Yang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Testosterone-mediated upregulation of delayed rectifier potassium channel in cardiomyocytes causes abbreviation of QT intervals in rats
- (2018) Kimiko Masuda et al. Journal of Physiological Sciences
- Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms
- (2018) Joachim Alexandre et al. PHARMACOLOGY & THERAPEUTICS
- CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities
- (2018) Filipa Lynce et al. PHARMACOLOGY & THERAPEUTICS
- Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment
- (2018) Hitisha K. Patel et al. PHARMACOLOGY & THERAPEUTICS
- Assessment of an In Silico Mechanistic Model for Proarrhythmia Risk Prediction Under the CiPA Initiative
- (2018) Zhihua Li et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women
- (2018) Joe-Elie Salem et al. JAMA Cardiology
- Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review
- (2018) Anthony Matthews et al. BMJ-British Medical Journal
- Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis
- (2017) Larysa H.M. Rydzewska et al. EUROPEAN JOURNAL OF CANCER
- Response to Letter: “Effects of Testosterone Replacement on Electrocardiographic Parameters in Men: Findings From Two Randomized Trials”
- (2017) Thiago Gagliano-Jucá et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A multiscale computational modelling approach predicts mechanisms of female sex risk in the setting of arousal-induced arrhythmias
- (2017) Pei-Chi Yang et al. JOURNAL OF PHYSIOLOGY-LONDON
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- (2017) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Management of Potential Toxicities and Drug Interactions Related to Cyclin‐Dependent Kinase 4/6 Inhibitors in Breast Cancer: Practical Considerations and Recommendations
- (2017) Laura M. Spring et al. ONCOLOGIST
- A mutation in the CACNA1C gene leads to early repolarization syndrome with incomplete penetrance: A Chinese family study
- (2017) Xin Liu et al. PLoS One
- Enzalutamide inhibits testosterone-induced growth of human prostate cancer xenografts in zebrafish and can induce bradycardia
- (2017) Nicole Melong et al. Scientific Reports
- Normalization of Testosterone Levels After Testosterone Replacement Therapy Is Associated With Decreased Incidence of Atrial Fibrillation
- (2017) Rishi Sharma et al. Journal of the American Heart Association
- GENomE wide analysis of sotalol-induced IKr inhibition during ventricular REPOLarization, “GENEREPOL study”: Lack of common variants with large effect sizes
- (2017) Joe-Elie Salem et al. PLoS One
- Phase 1 study of abemaciclib, an inhibitor of CDK 4 and 6, as a single agent for Japanese patients with advanced cancer
- (2016) Yutaka Fujiwara et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer
- (2016) Nirmanmoh Bhatia et al. CIRCULATION
- Kcne4 deletion sex- and age-specifically impairs cardiac repolarization in mice
- (2016) Shawn M. Crump et al. FASEB JOURNAL
- Complex Influence of Gonadotropins and Sex Steroid Hormones on QT Interval Duration
- (2016) Guillaume Abehsira et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Definition of First-Line Endocrine Therapy for Hormone Receptor–Positive Advanced Breast Cancer
- (2016) Tomás Reinert et al. JOURNAL OF CLINICAL ONCOLOGY
- Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
- (2016) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Arrhythmogenic effect of androgens on the rat heart
- (2016) Mariana Argenziano et al. Journal of Physiological Sciences
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Influence of steroid hormones on ventricular repolarization
- (2016) Joe-Elie Salem et al. PHARMACOLOGY & THERAPEUTICS
- Association of Biomarkers with Serious Cardiac Adverse Events during Abiraterone Acetate Treatment in Castration Resistant Prostate Cancer
- (2016) Sara Campora et al. Translational Oncology
- Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) C. Parker et al. ANNALS OF ONCOLOGY
- Endoxifen, the active metabolite of tamoxifen, inhibits cloned hERG potassium channels
- (2015) Yun Ju Chae et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Aldosterone and testosterone: two steroid hormones structurally related but with opposite electrophysiological properties during myocardial ischemia-reperfusion
- (2015) Joachim Alexandre et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Cytochrome P450 17A1 inhibitor abiraterone attenuates cellular growth of prostate cancer cells independently from androgen receptor signaling by modulation of oncogenic and apoptotic pathways
- (2015) HANNAH GROSSEBRUMMEL et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer
- (2015) Sean O'Farrell et al. JOURNAL OF CLINICAL ONCOLOGY
- Aromatase knockout mice reveal an impact of estrogen on drug-induced alternation of murine electrocardiography parameters
- (2015) Junko Kurokawa et al. JOURNAL OF TOXICOLOGICAL SCIENCES
- Short QTc Interval in Males with Klinefelter Syndrome-Influence of CAG Repeat Length, Body Composition, and Testosterone Replacement Therapy
- (2015) INGER NORLYK JØRGENSEN et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- Mechanisms of sex and age differences in ventricular repolarization in humans
- (2014) Jose Vicente et al. AMERICAN HEART JOURNAL
- Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer
- (2014) David R. Ziehr et al. BJU INTERNATIONAL
- Screening for Acute I Kr Block Is Insufficient to Detect Torsades de Pointes Liability
- (2014) Tao Yang et al. CIRCULATION
- Effect of testosterone replacement therapy on cardiac performance and oxidative stress in orchidectomized rats
- (2013) S. M. Eleawa et al. Acta Physiologica
- Toremifene for Breast Cancer: A Review of 20 Years of Data
- (2013) Charles L. Vogel et al. Clinical Breast Cancer
- Testosterone Replacement Therapy Improves QTaVI in Hypogonadal Men with Spinal Cord Injury
- (2013) Michael F. La Fountaine et al. NEUROENDOCRINOLOGY
- Estrogen synthesis and signaling pathways during aging: from periphery to brain
- (2013) Jie Cui et al. TRENDS IN MOLECULAR MEDICINE
- The blockade of angiotensin AT1and aldosterone receptors protects rats from synthetic androgen-induced cardiac autonomic dysfunction
- (2012) S. R. Marques Neto et al. Acta Physiologica
- Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancer
- (2012) A. W. Tolcher et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interaction of gonadal steroids and the glucocorticoid corticosterone in the regulation of the L-type Ca2+ current in rat left ventricular cardiomyocytes
- (2011) M. Wagner et al. Acta Physiologica
- Androgen Deprivation Therapy and the Risk of Coronary Heart Disease and Heart Failure in Patients with Prostate Cancer
- (2011) Elisa Martín-Merino et al. DRUG SAFETY
- Aldosterone promotes atrial fibrillation
- (2011) Jan-Christian Reil et al. EUROPEAN HEART JOURNAL
- Effects of testosterone on the Q-T Interval in older men and older women with chronic heart failure
- (2011) J. B. Schwartz et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- Androgen Deprivation Therapy and Competing Risks
- (2011) William K. Kelly et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical and Biochemical Consequences of CYP17A1 Inhibition with Abiraterone Given with and without Exogenous Glucocorticoids in Castrate Men with Advanced Prostate Cancer
- (2011) Gerhardt Attard et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aromatase inhibitors in men: effects and therapeutic options
- (2011) Willem de Ronde et al. Reproductive Biology and Endocrinology
- Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk
- (2010) Glenn N. Levine et al. CIRCULATION
- Influence of Sex Hormones on Cancer Progression
- (2010) Elizabeth J. Folkerd et al. JOURNAL OF CLINICAL ONCOLOGY
- Chronic treatment with anabolic steroids induces ventricular repolarization disturbances: Cellular, ionic and molecular mechanism
- (2010) Emiliano Medei et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Cardiovascular Safety of Degarelix: Results From a 12-Month, Comparative, Randomized, Open Label, Parallel Group Phase III Trial in Patients With Prostate Cancer
- (2010) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Acute Effects of Sex Steroid Hormones on Susceptibility to Cardiac Arrhythmias: A Simulation Study
- (2010) Pei-Chi Yang et al. PLoS Computational Biology
- Effects of Testosterone on Ventricular Repolarization in Hypogonadic Men
- (2009) Beny Charbit et al. AMERICAN JOURNAL OF CARDIOLOGY
- Increased prevalence of prolonged QT interval in males with primary or secondary hypogonadism: A pilot study
- (2009) F. Pecori Giraldi et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer
- (2008) Laurence Klotz et al. BJU INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search